Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an injectable solution for intravenous use. By inhibiting the gastric H⁺/K⁺ ATPase pump, it markedly lowers gastric acid production and is indicated for gastro‑esophageal reflux disease, erosive esophagitis, peptic ulcer disease, and the prevention of NSAID‑induced gastric ulcers.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Nexium (esomeprazole) is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastro‑esophageal reflux disease (GERD): Reduces acid exposure and promotes healing of esophageal irritation. - Erosive esophagitis: Facilitates mucosal repair by maintaining a higher gastric pH. - Peptic ulcer disease: Supports ulcer healing and reduces risk of recurrence. - Prevention of NSAID‑induced gastric ulcers: Provides protective acid suppression for patients on chronic NSAID therapy.

Adverse reactions may occur with any medication and should be monitored by the prescribing clinician.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring during therapy. - Nausea: transient feeling of queasiness. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reaction: requires immediate medical attention. - Clostridioides difficile infection: may cause severe colitis. - Hypomagnesemia: low serum magnesium with prolonged use. - Hepatic enzyme elevation: increased ALT/AST levels. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions. - Acute interstitial nephritis: renal inflammation presenting with fever and rash.

Before initiating therapy, clinicians should consider several safety aspects.

- Assess renal function: Adjust use in severe renal impairment. - Monitor magnesium levels: Prolonged therapy may cause hypomagnesemia. - Avoid in known hypersensitivity: Discontinue if allergic reaction occurs. - Use caution in hepatic impairment: Dose may need adjustment. - Pregnancy and lactation: Safety not established; weigh benefits against risks. - Store at 2‑8 °C: Keep refrigerated, protect from light, do not freeze or shake.

Esomeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Ketoconazole and other azole antifungals: Reduced absorption of the antifungal. - Atazanavir: Decreased plasma levels of atazanavir, compromising efficacy. - Clopidogrel: Reduced activation of clopidogrel, diminishing antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: May increase INR and bleeding risk. - Digoxin: Potential increase in serum digoxin concentrations. - Methotrexate: Reduced clearance leading to higher systemic exposure.